Thoratec   Report issue

For profit Phase 1
Founded: Pleasanton CA United States (1976)
Status: No NME R&D (1976)

Organization Overview

First Clinical Trial
2007
NCT00585546
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Thoratec Corporation

Active Ingredients

Drugs in Phase 1 Trials (3)

autologous mesenchymal stem cells (1 trial)

milrinone (primacor) (1 trial)

octreotide (sandostatin) (1 trial)

Drugs in Other Trials (1)

clenbuterol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastrointestinal Hemorrhage (Phase 1)

Heart Diseases (Phase 1)

Hemorrhage (Phase 1)

Ischemia (Phase 1)

Myocardial Ischemia (Phase 1)

Ventricular Dysfunction (Phase 1)

Ventricular Dysfunction, Right (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 4